Thales to Deliver Digital Licence Solution to Queensland, Australia
Thales has signed a contract to partner with Queensland’s Department of Transport and Main Roads (TMR) in Australia and local Queensland SMEs, Code Heroes and Aliva, to design, develop and deliver the State’s first Digital Licence App.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200107005628/en/
Thales Gemalto Digital ID Wallet (Photo: Thales)
Thales worked closely with TMR and their customers to co-design a fully integrated app-based solution that is able to manage multiple digital credentials from various sources. The comprehensive solution that integrates a backend platform with managed services, builds upon Gemalto’s next generation Digital ID Platform and Wallet technology, a globally proven and secure, smartphone-based home for all of the owner's digital identity credentials.
Thales completed the acquisition of Gemalto in April 2019 during the TMR procurement process, acquiring a set of highly complementary technologies and competencies, and reinforcing Thales’s status as a world-leader in digital identity and security.
The all-in-one Digital Licence solution utilises a privacy enhanced app that acts as a secure digital vault to store a wide range of digitalized official documents, starting with the owner’s Driver’s Licence, Photo Identification Card, Marine Licence and vehicle registration. The innovative solution delivers ease of access via a smartphone, while ensuring the owner has complete control over their personal data and the freedom to decide exactly what information to share, with whom, and when.
The app will also provide Queenslanders with a secure gateway to access TMR’s online services, supporting the opportunity to expand to other State Government online services in the future.
The innovative solution will be piloted in the Fraser Coast in early 2020, before extending to other regional locations and becoming available to over 3.7 million Queenslanders state-wide.
A first for Australia, Queensland’s Digital Licence will meet the International ISO-Compliant Mobile Driving Licence Standard, allowing the State’s digital driver’s licences to be recognised and used in over 18 countries world-wide including the US, UK and France.
Thales Australia CEO, Chris Jenkins said
“We are excited to be partnering with the Queensland Government to deliver our secure Digital ID Wallet solution. This is the first major contract award in Australia that has resulted from the merger of Thales and Gemalto. The bringing together of two technology powerhouses has strengthened Thales’s position as a world leader in digital security. The Queensland Digital Licence end-to-end solution contract is a demonstration of the success of the integration.”
Note to Editors
Gemalto's solutions are at the heart of modern life, from payments to enterprise security and the internet of things. They authenticate people, transactions and objects, encrypt data and create value for software - enabling companies and governments to deliver secure digital services for billions of individuals and things.
About Thales
The people who make the world go round – they rely on Thales. Our customers come to us with big ambitions: to make life better, to keep us safer. Combining a unique diversity of expertise, talents and cultures, our architects design and deliver extraordinary, high-technology solutions. Solutions that make tomorrow possible today. From the bottom of the oceans to the depths of space and cyberspace, we help our customers think smarter and act faster – mastering ever greater complexity at every decisive moment along the way.
Thales generated revenues of €19 billion in 2018 with 80 thousand employees in 68 countries.
PLEASE VISIT
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200107005628/en/
Contact information
Thales Digital Identity & Security
Vanessa Viala
+33 607340034
Vanessa.Viala@thalesgroup.com
Thales Australia
Jasmin Hilleard
+61 420 903 636
Jasmin.Hilleard@thalesgroup.com.au
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom